SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 1 filers reported holding SEAGEN INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $693,731 | +10.4% | 3,270 | +0.2% | 0.09% | +15.4% |
| Q2 2023 | $628,382 | -8.4% | 3,265 | -3.7% | 0.08% | -16.1% |
| Q1 2023 | $686,373 | +50.2% | 3,390 | -4.6% | 0.09% | +34.8% |
| Q4 2022 | $456,853 | -6.0% | 3,555 | 0.0% | 0.07% | -14.8% |
| Q3 2022 | $486,000 | +12.2% | 3,555 | +45.4% | 0.08% | +15.7% |
| Q2 2022 | $433,000 | +34.5% | 2,445 | +9.4% | 0.07% | +52.2% |
| Q1 2022 | $322,000 | +25.3% | 2,235 | +34.6% | 0.05% | +9.5% |
| Q4 2021 | $257,000 | -8.9% | 1,660 | 0.0% | 0.04% | -36.4% |
| Q3 2021 | $282,000 | +7.6% | 1,660 | 0.0% | 0.07% | +8.2% |
| Q2 2021 | $262,000 | +13.4% | 1,660 | 0.0% | 0.06% | -6.2% |
| Q1 2021 | $231,000 | -20.6% | 1,660 | 0.0% | 0.06% | -27.0% |
| Q4 2020 | $291,000 | – | 1,660 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |